Top

Published in:

01-11-2020 | Magnetic Resonance Imaging | Special Section: Diffuse Liver Disease.

Noninvasive imaging assessment of portal hypertension

Authors: Paul Kennedy, Octavia Bane, Stefanie J. Hectors, Aaron Fischman, Thomas Schiano, Sara Lewis, Bachir Taouli

Published in: Abdominal Radiology | Issue 11/2020

Abstract

Portal hypertension (PH) is a spectrum of complications of chronic liver disease (CLD) and cirrhosis, with manifestations including ascites, gastroesophageal varices, splenomegaly, hypersplenism, hepatic hydrothorax, hepatorenal syndrome, hepatopulmonary syndrome and portopulmonary hypertension. PH can vary in severity and is diagnosed via invasive hepatic venous pressure gradient measurement (HVPG), which is considered the reference standard. Accurate diagnosis of PH and assessment of severity are highly relevant as patients with clinically significant portal hypertension (CSPH) are at higher risk for developing acute variceal bleeding and mortality. In this review, we discuss current and upcoming noninvasive imaging methods for diagnosis and assessment of severity of PH.

Tapper EB, Parikh ND (2018) Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study. BMJ 362:k2817. https://doi.org/10.1136/bmj.k2817CrossRefPubMedPubMedCentral

Asrani SK, Larson JJ, Yawn B, Therneau TM, Kim WR (2013) Underestimation of liver-related mortality in the United States. Gastroenterology 145 (2):375-382 e371-372. https://doi.org/10.1053/j.gastro.2013.04.005

Forman-Hoffman VL, Ault KL, Anderson WL, Weiner JM, Stevens A, Campbell VA, Armour BS (2015) Disability status, mortality, and leading causes of death in the United States community population. Med Care 53 (4):346-354. https://doi.org/10.1097/mlr.0000000000000321CrossRefPubMedPubMedCentral

Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ (2018) Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 67 (1):123-133. https://doi.org/10.1002/hep.29466CrossRefPubMed

Beste LA, Leipertz SL, Green PK, Dominitz JA, Ross D, Ioannou GN (2015) Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013. Gastroenterology 149 (6):1471-1482 e1475; quiz e1417-1478. https://doi.org/10.1053/j.gastro.2015.07.056

Scaglione S, Kliethermes S, Cao G, Shoham D, Durazo R, Luke A, Volk ML (2015) The Epidemiology of Cirrhosis in the United States: A Population-based Study. J Clin Gastroenterol 49 (8):690-696. https://doi.org/10.1097/mcg.0000000000000208CrossRefPubMed

Moon AM, Singal AG, Tapper EB (2019) Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis. Clin Gastroenterol Hepatol. https://doi.org/10.1016/j.cgh.2019.07.060CrossRefPubMedPubMedCentral

Mellinger JL, Shedden K, Winder GS, Tapper E, Adams M, Fontana RJ, Volk ML, Blow FC, Lok ASF (2018) The high burden of alcoholic cirrhosis in privately insured persons in the United States. Hepatology 68 (3):872-882. https://doi.org/10.1002/hep.29887CrossRefPubMed

Nahon P, Bourcier V, Layese R, Audureau E, Cagnot C, Marcellin P, Guyader D, Fontaine H, Larrey D, De Ledinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Leroy V, Riachi G, Cales P, Peron JM, Alric L, Bourliere M, Mathurin P, Dharancy S, Blanc JF, Abergel A, Serfaty L, Mallat A, Grange JD, Attali P, Bacq Y, Wartelle C, Dao T, Benhamou Y, Pilette C, Silvain C, Christidis C, Capron D, Bernard-Chabert B, Zucman D, Di Martino V, Thibaut V, Salmon D, Ziol M, Sutton A, Pol S, Roudot-Thoraval F, Group ACC (2017) Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications. Gastroenterology 152 (1):142-156 e142. https://doi.org/10.1053/j.gastro.2016.09.009

10.

Kao JH, Chen DS (2002) Global control of hepatitis B virus infection. Lancet Infect Dis 2 (7):395-403. https://doi.org/10.1016/s1473-3099(02)00315-8CrossRefPubMed

11.

Zanetti AR, Van Damme P, Shouval D (2008) The global impact of vaccination against hepatitis B: a historical overview. Vaccine 26 (49):6266-6273. https://doi.org/10.1016/j.vaccine.2008.09.056CrossRefPubMed

12.

Jafri SM, Lok AS (2010) Antiviral therapy for chronic hepatitis B. Clin Liver Dis 14 (3):425-438. https://doi.org/10.1016/j.cld.2010.05.005CrossRefPubMed

13.

Khanna R, Sarin SK (2014) Non-cirrhotic portal hypertension - diagnosis and management. J Hepatol 60 (2):421-441. https://doi.org/10.1016/j.jhep.2013.08.013CrossRefPubMed

14.

McConnell M, Iwakiri Y (2018) Biology of portal hypertension. Hepatol Int 12 (Suppl 1):11-23. https://doi.org/10.1007/s12072-017-9826-xCrossRefPubMed

15.

Berzigotti A, Bosch J (2014) Pharmacologic management of portal hypertension. Clin Liver Dis 18 (2):303-317. https://doi.org/10.1016/j.cld.2013.12.003CrossRefPubMed

16.

Strauss RM, Boyer TD (1997) Hepatic hydrothorax. Semin Liver Dis 17 (3):227-232. https://doi.org/10.1055/s-2007-1007200CrossRefPubMed

17.

Hoeper MM, Krowka MJ, Strassburg CP (2004) Portopulmonary hypertension and hepatopulmonary syndrome. Lancet 363 (9419):1461-1468. https://doi.org/10.1016/s0140-6736(04)16107-2CrossRefPubMed

18.

Krowka MJ, Dickson ER, Cortese DA (1993) Hepatopulmonary syndrome. Clinical observations and lack of therapeutic response to somatostatin analogue. Chest 104 (2):515-521. https://doi.org/10.1378/chest.104.2.515

19.

Hadengue A, Benhayoun MK, Lebrec D, Benhamou JP (1991) Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology 100 (2):520-528. https://doi.org/10.1016/0016-5085(91)90225-aCrossRefPubMed

20.

Shah SH, Hayes PC, Allan PL, Nicoll J, Finlayson ND (1996) Measurement of spleen size and its relation to hypersplenism and portal hemodynamics in portal hypertension due to hepatic cirrhosis. Am J Gastroenterol 91 (12):2580-2583PubMed

21.

de Franchis R, Baveno VIF (2015) Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 63 (3):743-752. https://doi.org/10.1016/j.jhep.2015.05.022CrossRefPubMed

22.

Kennedy P, Wagner M, Castera L, Hong CW, Johnson CL, Sirlin CB, Taouli B (2018) Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions. Radiology 286 (3):738-763. https://doi.org/10.1148/radiol.2018170601CrossRefPubMed

23.

Merkel C, Bolognesi M, Bellon S, Zuin R, Noventa F, Finucci G, Sacerdoti D, Angeli P, Gatta A (1992) Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. Gastroenterology 102 (3):973-979. https://doi.org/10.1016/0016-5085(92)90185-2CrossRefPubMed

24.

Moitinho E, Escorsell A, Bandi JC, Salmerón JM, García-Pagán JC, Rodés J, Bosch J (1999) Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 117 (3):626-631. https://doi.org/10.1016/s0016-5085(99)70455-5CrossRefPubMed

25.

Ripoll C, Bañares R, Rincón D, Catalina M-V, Lo Iacono O, Salcedo M, Clemente G, Núñez O, Matilla A, Molinero L-M (2005) Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era. Hepatology (Baltimore, Md) 42 (4):793-801. https://doi.org/10.1002/hep.20871CrossRef

26.

Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Makuch R, Patch D, Matloff DS, Bosch J, Portal Hypertension Collaborative G (2007) Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 133 (2):481-488. https://doi.org/10.1053/j.gastro.2007.05.024CrossRefPubMed

27.

Albillos A, Banares R, Gonzalez M, Ripoll C, Gonzalez R, Catalina MV, Molinero LM (2007) Value of the hepatic venous pressure gradient to monitor drug therapy for portal hypertension: a meta-analysis. Am J Gastroenterol 102 (5):1116-1126. https://doi.org/10.1111/j.1572-0241.2007.01191.xCrossRefPubMed

28.

Sawyerr AM, McCormick PA, Tennyson GS, Chin J, Dick R, Scheuer PJ, Burroughs AK, McIntyre N (1993) A comparison of transjugular and plugged-percutaneous liver biopsy in patients with impaired coagulation. J Hepatol 17 (1):81-85. https://doi.org/10.1016/s0168-8278(05)80525-2CrossRefPubMed

29.

Ripoll C, Groszmann RJ, Garcia-Tsao G, Bosch J, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Makuch R, Patch D, Matloff DS (2009) Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. Journal of Hepatology 50 (5):923-928. https://doi.org/10.1016/j.jhep.2009.01.014CrossRefPubMedPubMedCentral

30.

Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, Escorsell A, Garcia-Pagan JC, Patch D, Matloff DS, Gao H, Makuch R, Portal Hypertension Collaborative G (2005) Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 353 (21):2254-2261. https://doi.org/10.1056/nejmoa044456CrossRefPubMed

31.

Garcia-Tsao G (2005) Transjugular Intrahepatic Portosystemic Shunt in the Management of Refractory Ascites. Semin intervent Radiol 22 (04):278-286. https://doi.org/10.1055/s-2005-925554CrossRefPubMedPubMedCentral

32.

Suk KT (2014) Hepatic venous pressure gradient: clinical use in chronic liver disease. Clin Mol Hepatol 20 (1):6-14. https://doi.org/10.3350/cmh.2014.20.1.6CrossRefPubMedPubMedCentral

33.

Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R (2004) Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 40 (3):652-659. https://doi.org/10.1002/hep.20339CrossRefPubMed

34.

Garcia-Tsao G, Sanyal AJ, Grace ND, Carey WD, Practice Guidelines Committee of American Association for Study of Liver D, Practice Parameters Committee of American College of G (2007) Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Am J Gastroenterol 102 (9):2086-2102. https://doi.org/10.1111/j.1572-0241.2007.01481.xCrossRef

35.

Inokuchi K, Japanese Research Society for Portal H (1980) The General rules for recording endoscopic findings on esophageal varices. The Japanese journal of surgery 10 (1):84-87. https://doi.org/10.1007/bf02468653CrossRef

36.

Fateen W, Ragunath K, White J, Khanna A, Coletta M, Samuel S, Ortiz J, James M, Wilkes E, Aithal GP, Guha IN, Sami SS (2020) Validation of the AASLD recommendations for classification of oesophageal varices in clinical practice. Liver Int 40 (4):905-912. https://doi.org/10.1111/liv.14310CrossRefPubMed

37.

Simon K, Orlowska I, Pazgan-Simon M (2017) The risk of complications of endoscopic procedures in patients with liver cirrhosis. Clin Exp Hepatol 3 (3):135-140. https://doi.org/10.5114/ceh.2017.70284CrossRefPubMedPubMedCentral

38.

Procopet B, Berzigotti A (2017) Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy. Gastroenterol Rep (Oxf) 5 (2):79-89. https://doi.org/10.1093/gastro/gox012CrossRef

39.

Bandali MF, Mirakhur A, Lee EW, Ferris MC, Sadler DJ, Gray RR, Wong JK (2017) Portal hypertension: Imaging of portosystemic collateral pathways and associated image-guided therapy. World J Gastroenterol 23 (10):1735-1746. https://doi.org/10.3748/wjg.v23.i10.1735CrossRefPubMedPubMedCentral

40.

Lafortune M, Constantin A, Breton G, Legare A, Lavoie P (1985) The recanalized umbilical vein in portal hypertension: a myth. American Journal of Roentgenology 144 (3):549-553. https://doi.org/10.2214/ajr.144.3.549CrossRefPubMed

41.

Perri RE, Chiorean MV, Fidler JL, Fletcher JG, Talwalkar JA, Stadheim L, Shah ND, Kamath PS (2008) A prospective evaluation of computerized tomographic (CT) scanning as a screening modality for esophageal varices. Hepatology 47 (5):1587-1594. https://doi.org/10.1002/hep.22219CrossRefPubMed

42.

Kim YJ, Raman SS, Yu NC, To’o KJ, Jutabha R, Lu DS (2007) Esophageal varices in cirrhotic patients: evaluation with liver CT. AJR Am J Roentgenol 188 (1):139-144. https://doi.org/10.2214/ajr.05.1737CrossRefPubMed

43.

Matsuo M, Kanematsu M, Kim T, Hori M, Takamura M, Murakami T, Kondo H, Moriyama N, Nakamura H, Hoshi H (2003) Esophageal varices: diagnosis with gadolinium-enhanced MR imaging of the liver for patients with chronic liver damage. AJR Am J Roentgenol 180 (2):461-466. https://doi.org/10.2214/ajr.180.2.1800461CrossRefPubMed

44.

Lipp MJ, Broder A, Hudesman D, Suwandhi P, Okon SA, Horowitz M, Clain DJ, Friedmann P, Min AD (2011) Detection of esophageal varices using CT and MRI. Dig Dis Sci 56 (9):2696-2700. https://doi.org/10.1007/s10620-011-1660-8CrossRefPubMed

45.

Yu NC, Margolis D, Hsu M, Raman SS, Lu DS (2011) Detection and grading of esophageal varices on liver CT: comparison of standard and thin-section multiplanar reconstructions in diagnostic accuracy. AJR Am J Roentgenol 197 (3):643-649. https://doi.org/10.2214/ajr.10.5458CrossRefPubMed

46.

Goshima S, Kanematsu M, Kondo H, Tsuge Y, Watanabe H, Shiratori Y, Onozuka M, Moriyama N (2009) Detection and grading for esophageal varices in patients with chronic liver damage: comparison of gadolinium-enhanced and unenhanced steady-state coherent MR images. Magn Reson Imaging 27 (9):1230-1235. https://doi.org/10.1016/j.mri.2009.05.030CrossRefPubMed

47.

Tarantino G, Citro V, Conca P, Riccio A, Tarantino M, Capone D, Cirillo M, Lobello R, Iaccarino V (2009) What are the implications of the spontaneous spleno-renal shunts in liver cirrhosis? BMC Gastroenterol 9:89. https://doi.org/10.1186/1471-230x-9-89CrossRefPubMedPubMedCentral

48.

Simon-Talero M, Roccarina D, Martinez J, Lampichler K, Baiges A, Low G, Llop E, Praktiknjo M, Maurer MH, Zipprich A, Triolo M, Vangrinsven G, Garcia-Martinez R, Dam A, Majumdar A, Picon C, Toth D, Darnell A, Abraldes JG, Lopez M, Kukuk G, Krag A, Banares R, Laleman W, La Mura V, Ripoll C, Berzigotti A, Trebicka J, Calleja JL, Tandon P, Hernandez-Gea V, Reiberger T, Albillos A, Tsochatzis EA, Augustin S, Genesca J, Baveno VISgftBC (2018) Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis. Gastroenterology 154 (6):1694-1705 e1694. https://doi.org/10.1053/j.gastro.2018.01.028

49.

Praktiknjo M, Simon-Talero M, Romer J, Roccarina D, Martinez J, Lampichler K, Baiges A, Low G, Llop E, Maurer MH, Zipprich A, Triolo M, Maleux G, Fialla AD, Dam C, Vidal-Gonzalez J, Majumdar A, Picon C, Toth D, Darnell A, Abraldes JG, Lopez M, Jansen C, Chang J, Schierwagen R, Uschner F, Kukuk G, Meyer C, Thomas D, Wolter K, Strassburg CP, Laleman W, La Mura V, Ripoll C, Berzigotti A, Calleja JL, Tandon P, Hernandez-Gea V, Reiberger T, Albillos A, Tsochatzis EA, Krag A, Genesca J, Trebicka J, Baveno VISgotBC (2020) Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis. J Hepatol 72 (6):1140-1150. https://doi.org/10.1016/j.jhep.2019.12.021CrossRefPubMed

50.

Sagoh T, Itoh K, Togashi K, Shibata T, Nishimura K, Minami S, Asato R, Noma S, Fujisawa I, Yamashita K, et al. (1989) Gamna-Gandy bodies of the spleen: evaluation with MR imaging. Radiology 172 (3):685-687. https://doi.org/10.1148/radiology.172.3.2672093CrossRefPubMed

51.

Berzigotti A, Seijo S, Arena U, Abraldes JG, Vizzutti F, Garcia-Pagan JC, Pinzani M, Bosch J (2013) Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterology 144 (1):102-111 e101. https://doi.org/10.1053/j.gastro.2012.10.001

52.

Kihira S, Kagen AC, Vasudevan P, Jajamovich GH, Schiano TD, Andrle AF, Babb JS, Fischman A, Taouli B (2016) Non-invasive prediction of portal pressures using CT and MRI in chronic liver disease. Abdom Radiol (NY) 41 (1):42-49. https://doi.org/10.1007/s00261-015-0614-6CrossRef

53.

Zironi G, Gaiani S, Fenyves D, Rigamonti A, Bolondi L, Barbara L (1992) Value of measurement of mean portal flow velocity by Doppler flowmetry in the diagnosis of portal hypertension. J Hepatol 16 (3):298-303. https://doi.org/10.1016/s0168-8278(05)80660-9CrossRefPubMed

54.

Lee JY, Kim TY, Jeong WK, Kim Y, Kim J, Kim KW, Kim YH, Sohn JH (2014) Clinically severe portal hypertension: role of multi-detector row CT features in diagnosis. Dig Dis Sci 59 (9):2333-2343. https://doi.org/10.1007/s10620-014-3149-8CrossRefPubMed

55.

Iranmanesh P, Vazquez O, Terraz S, Majno P, Spahr L, Poncet A, Morel P, Mentha G, Toso C (2014) Accurate computed tomography-based portal pressure assessment in patients with hepatocellular carcinoma. J Hepatol 60 (5):969-974. https://doi.org/10.1016/j.jhep.2013.12.015CrossRefPubMed

56.

Sartoris R, Rautou PE, Elkrief L, Pollorsi G, Durand F, Valla D, Spahr L, Terraz S, Soubrane O, Cauchy F, Vilgrain V, Ronot M (2018) Quantification of Liver Surface Nodularity at CT: Utility for Detection of Portal Hypertension. Radiology 289 (3):698-707. https://doi.org/10.1148/radiol.2018181131CrossRefPubMed

57.

De Vos N, Sartoris R, Cauchy F, Rautou PE, Vilgrain V, Ronot M (2020) Performance of liver surface nodularity quantification for the diagnosis of portal hypertension in patients with cirrhosis: comparison between MRI with hepatobiliary phase sequences and CT. Abdom Radiol (NY) 45 (2):365-372. https://doi.org/10.1007/s00261-019-02355-yCrossRef

58.

Lo GC, Besa C, King MJ, Kang M, Stueck A, Thung S, Wagner M, Smith AD, Taouli B (2017) Feasibility and reproducibility of liver surface nodularity quantification for the assessment of liver cirrhosis using CT and MRI. Eur J Radiol Open 4:95-100. https://doi.org/10.1016/j.ejro.2017.07.001CrossRefPubMedPubMedCentral

59.

Besa C, Wagner M, Lo G, Gordic S, Chatterji M, Kennedy P, Stueck A, Thung S, Babb J, Smith A, Taouli B (2018) Detection of liver fibrosis using qualitative and quantitative MR elastography compared to liver surface nodularity measurement, gadoxetic acid uptake, and serum markers. J Magn Reson Imaging 47 (6):1552-1561. https://doi.org/10.1002/jmri.25911CrossRefPubMed

60.

Sartoris R, Lazareth M, Nivolli A, Dioguardi Burgio M, Vilgrain V, Ronot M (2020) CT-based liver surface nodularity for the detection of clinically significant portal hypertension: defining measurement quality criteria. Abdom Radiol (NY). https://doi.org/10.1007/s00261-020-02519-1CrossRef

61.

Li Y, Huang YS, Wang ZZ, Yang ZR, Sun F, Zhan SY, Liu XE, Zhuang H (2016) Systematic review with meta-analysis: the diagnostic accuracy of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B. Aliment Pharmacol Ther 43 (4):458-469. https://doi.org/10.1111/apt.13488CrossRefPubMed

62.

Njei B, McCarty TR, Luk J, Ewelukwa O, Ditah I, Lim JK (2016) Use of transient elastography in patients with HIV–HCV coinfection: A systematic review and meta-analysis. Journal of Gastroenterology and Hepatology 31 (10):1684-1693. https://doi.org/10.1111/jgh.13337CrossRefPubMedPubMedCentral

63.

Chon YE, Choi EH, Song KJ, Park JY, Kim DY, Han K-H, Chon CY, Ahn SH, Kim SU (2012) Performance of Transient Elastography for the Staging of Liver Fibrosis in Patients with Chronic Hepatitis B: A Meta-Analysis. PLOS ONE 7 (9):e44930. https://doi.org/10.1371/journal.pone.0044930CrossRefPubMedPubMedCentral

64.

Tsochatzis EA, Gurusamy KS, Ntaoula S, Cholongitas E, Davidson BR, Burroughs AK (2011) Elastography for the diagnosis of severity of fibrosis in chronic liver disease: A meta-analysis of diagnostic accuracy. Journal of Hepatology 54 (4):650-659. https://doi.org/10.1016/j.jhep.2010.07.033CrossRefPubMed

65.

Stebbing J, Farouk L, Panos G, Anderson M, Jiao LR, Mandalia S, Bower M, Gazzard B, Nelson M (2010) A meta-analysis of transient elastography for the detection of hepatic fibrosis. J Clin Gastroenterol 44 (3):214-219. https://doi.org/10.1097/mcg.0b013e3181b4af1fCrossRefPubMed

66.

Friedrich–Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, Herrmann E (2008) Performance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-Analysis. Gastroenterology 134 (4):960-974.e968. https://doi.org/10.1053/j.gastro.2008.01.034CrossRefPubMed

67.

Talwalkar JA, Kurtz DM, Schoenleber SJ, West CP, Montori VM (2007) Ultrasound-Based Transient Elastography for the Detection of Hepatic Fibrosis: Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 5 (10):1214-1220. https://doi.org/10.1016/j.cgh.2007.07.020CrossRefPubMed

68.

Shaheen AAM, Wan AF, Myers RP (2007) FibroTest and FibroScan for the Prediction of Hepatitis C-Related Fibrosis: A Systematic Review of Diagnostic Test Accuracy. The American Journal of Gastroenterology 102 (11):2589-2600. https://doi.org/10.1111/j.1572-0241.2007.01466.xCrossRefPubMed

69.

Shi K-Q, Fan Y-C, Pan Z-Z, Lin X-F, Liu W-Y, Chen Y-P, Zheng M-H (2013) Transient elastography: a meta-analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease. Liver International 33 (1):62-71. https://doi.org/10.1111/liv.12003CrossRefPubMed

70.

You M-W, Kim KW, Pyo J, Huh J, Kim HJ, Lee SJ, Park SH (2017) A Meta-analysis for the Diagnostic Performance of Transient Elastography for Clinically Significant Portal Hypertension. Ultrasound in Medicine & Biology 43 (1):59-68. https://doi.org/10.1016/j.ultrasmedbio.2016.07.025CrossRef

71.

Augustin S, Millán L, González A, Martell M, Gelabert A, Segarra A, Serres X, Esteban R, Genescà J (2014) Detection of early portal hypertension with routine data and liver stiffness in patients with asymptomatic liver disease: A prospective study. Journal of Hepatology 60 (3):561-569. https://doi.org/10.1016/j.jhep.2013.10.027CrossRefPubMed

72.

Abraldes JG, Bureau C, Stefanescu H, Augustin S, Ney M, Blasco H, Procopet B, Bosch J, Genesca J, Berzigotti A, Anticipate I (2016) Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The “Anticipate” study. Hepatology 64 (6):2173-2184. https://doi.org/10.1002/hep.28824CrossRefPubMed

73.

Augustin S, Pons M, Maurice JB, Bureau C, Stefanescu H, Ney M, Blasco H, Procopet B, Tsochatzis E, Westbrook RH, Bosch J, Berzigotti A, Abraldes JG, Genescà J (2017) Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease. Hepatology 66 (6):1980-1988. https://doi.org/10.1002/hep.29363CrossRefPubMed

74.

Pu K, Shi J-H, Wang X, Tang Q, Wang X-J, Tang K-L, Long Z-Q, Hu X-S (2017) Diagnostic accuracy of transient elastography (FibroScan) in detection of esophageal varices in patients with cirrhosis: A meta-analysis. World Journal of Gastroenterology 23 (2):345-356. https://doi.org/10.3748/wjg.v23.i2.345CrossRefPubMedPubMedCentral

75.

Colecchia A, Montrone L, Scaioli E, Bacchi–Reggiani ML, Colli A, Casazza G, Schiumerini R, Turco L, Biase ARD, Mazzella G, Marzi L, Arena U, Pinzani M, Festi D (2012) Measurement of Spleen Stiffness to Evaluate Portal Hypertension and the Presence of Esophageal Varices in Patients With HCV-Related Cirrhosis. Gastroenterology 143 (3):646-654. https://doi.org/10.1053/j.gastro.2012.05.035CrossRefPubMed

76.

Calvaruso V, Bronte F, Conte E, Simone F, Craxì A, Di Marco V (2013) Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated hepatitis C virus cirrhosis. Journal of Viral Hepatitis 20 (12):867-874. https://doi.org/10.1111/jvh.12114CrossRefPubMed

77.

Sharma P, Kirnake V, Tyagi P, Bansal N, Singla V, Kumar A, Arora A (2013) Spleen Stiffness in Patients With Cirrhosis in Predicting Esophageal Varices. The American Journal of Gastroenterology 108 (7):1101-1107. https://doi.org/10.1038/ajg.2013.119CrossRefPubMed

78.

Stefanescu H, Grigorescu M, Lupsor M, Procopet B, Maniu A, Badea R (2011) Spleen stiffness measurement using fibroscan for the noninvasive assessment of esophageal varices in liver cirrhosis patients. Journal of Gastroenterology and Hepatology 26 (1):164-170. https://doi.org/10.1111/j.1440-1746.2010.06325.xCrossRefPubMed

79.

Colecchia A, Ravaioli F, Marasco G, Colli A, Dajti E, Di Biase AR, Bacchi Reggiani ML, Berzigotti A, Pinzani M, Festi D (2018) A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease. Journal of Hepatology 69 (2):308-317. https://doi.org/10.1016/j.jhep.2018.04.023CrossRefPubMed

80.

Morishita N, Hiramatsu N, Oze T, Harada N, Yamada R, Miyazaki M, Yakushijin T, Miyagi T, Yoshida Y, Tatsumi T, Kanto T, Takehara T (2014) Liver stiffness measurement by acoustic radiation force impulse is useful in predicting the presence of esophageal varices or high-risk esophageal varices among patients with HCV-related cirrhosis. Journal of Gastroenterology 49 (7):1175-1182. https://doi.org/10.1007/s00535-013-0877-zCrossRefPubMed

81.

Elkrief L, Rautou P-E, Ronot M, Lambert S, Dioguardi Burgio M, Francoz C, Plessier A, Durand F, Valla D, Lebrec D, Vilgrain V, Castéra L (2014) Prospective Comparison of Spleen and Liver Stiffness by Using Shear-Wave and Transient Elastography for Detection of Portal Hypertension in Cirrhosis. Radiology 275 (2):589-598. https://doi.org/10.1148/radiol.14141210CrossRefPubMed

82.

Cassinotto C, Charrie A, Mouries A, Lapuyade B, Hiriart J-B, Vergniol J, Gaye D, Hocquelet A, Charbonnier M, Foucher J, Laurent F, Chermak F, Montaudon M, de Ledinghen V (2015) Liver and spleen elastography using supersonic shear imaging for the non-invasive diagnosis of cirrhosis severity and oesophageal varices. Digestive and Liver Disease 47 (8):695-701. https://doi.org/10.1016/j.dld.2015.04.008CrossRefPubMed

83.

Takuma Y, Morimoto Y, Takabatake H, Toshikuni N, Tomokuni J, Sahara A, Matsueda K, Yamamoto H (2016) Measurement of Spleen Stiffness With Acoustic Radiation Force Impulse Imaging Predicts Mortality and Hepatic Decompensation in Patients With Liver Cirrhosis. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2016.10.041CrossRefPubMed

84.

Takuma Y, Nouso K, Morimoto Y, Tomokuni J, Sahara A, Takabatake H, Matsueda K, Yamamoto H (2016) Portal Hypertension in Patients with Liver Cirrhosis: Diagnostic Accuracy of Spleen Stiffness. Radiology 279 (2):609-619. https://doi.org/10.1148/radiol.2015150690CrossRefPubMed

85.

Thiele M, Hugger MB, Kim Y, Rautou PE, Elkrief L, Jansen C, Verlinden W, Allegretti G, Israelsen M, Stefanescu H, Piscaglia F, Garcia-Pagan JC, Franque S, Berzigotti A, Castera L, Jeong WK, Trebicka J, Krag A (2020) 2D shear wave liver elastography by Aixplorer to detect portal hypertension in cirrhosis: An individual patient data meta-analysis. Liver Int 40 (6):1435-1446. https://doi.org/10.1111/liv.14439CrossRefPubMed

86.

Singh S, Venkatesh SK, Loomba R, Wang Z, Sirlin C, Chen J, Yin M, Miller FH, Low RN, Hassanein T, Godfrey EM, Asbach P, Murad MH, Lomas DJ, Talwalkar JA, Ehman RL (2016) Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis. Eur Radiol 26 (5):1431-1440. https://doi.org/10.1007/s00330-015-3949-zCrossRefPubMed

87.

Singh S, Venkatesh SK, Wang Z, Miller FH, Motosugi U, Low RN, Hassanein T, Asbach P, Godfrey EM, Yin M, Chen J, Keaveny AP, Bridges M, Bohte A, Murad MH, Lomas DJ, Talwalkar JA, Ehman RL (2015) Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol 13 (3):440-451 e446. https://doi.org/10.1016/j.cgh.2014.09.046

88.

Dyvorne HA, Jajamovich GH, Besa C, Cooper N, Taouli B (2015) Simultaneous measurement of hepatic and splenic stiffness using MR elastography: preliminary experience. Abdom Imaging 40 (4):803-809. https://doi.org/10.1007/s00261-014-0255-1CrossRefPubMedPubMedCentral

89.

Yasar TK, Wagner M, Bane O, Besa C, Babb JS, Kannengiesser S, Fung M, Ehman RL, Taouli B (2016) Interplatform reproducibility of liver and spleen stiffness measured with MR elastography. J Magn Reson Imaging 43 (5):1064-1072. https://doi.org/10.1002/jmri.25077CrossRefPubMed

90.

Guo J, Büning C, Schott E, Kröncke T, Braun J, Sack I, Althoff C (2015) In Vivo Abdominal Magnetic Resonance Elastography for the Assessment of Portal Hypertension Before and After Transjugular Intrahepatic Portosystemic Shunt Implantation. Investigative Radiology 50 (5):347-351. https://doi.org/10.1097/rli.0000000000000136CrossRefPubMed

91.

Morisaka H, Motosugi U, Ichikawa S, Sano K, Ichikawa T, Enomoto N (2015) Association of splenic MR elastographic findings with gastroesophageal varices in patients with chronic liver disease. J Magn Reson Imaging 41 (1):117-124. https://doi.org/10.1002/jmri.24505CrossRefPubMed

92.

Ronot M, Lambert S, Elkrief L, Doblas S, Rautou P-E, Castera L, Vilgrain V, Sinkus R, Beers BEV, Garteiser P (2014) Assessment of portal hypertension and high-risk oesophageal varices with liver and spleen three-dimensional multifrequency MR elastography in liver cirrhosis. European Radiology 24 (6):1394-1402. https://doi.org/10.1007/s00330-014-3124-yCrossRefPubMed

93.

Shin SU, Lee J-M, Yu MH, Yoon JH, Han JK, Choi B-I, Glaser KJ, Ehman RL (2014) Prediction of Esophageal Varices in Patients with Cirrhosis: Usefulness of Three-dimensional MR Elastography with Echo-planar Imaging Technique. Radiology 272 (1):143-153. https://doi.org/10.1148/radiol.14130916CrossRefPubMed

94.

Talwalkar JA, Yin M, Venkatesh S, Rossman PJ, Grimm RC, Manduca A, Romano A, Kamath PS, Ehman RL (2009) Feasibility and Significance of in vivo Mean Spleen Stiffness Measurement by Magnetic Resonance Elastography for Assessing Portal Hypertension. AJR American journal of roentgenology 193 (1):122-127. https://doi.org/10.2214/ajr.07.3504CrossRefPubMedPubMedCentral

95.

Singh R, Wilson MP, Katlariwala P, Murad MH, McInnes MDF, Low G (2020) Accuracy of liver and spleen stiffness on magnetic resonance elastography for detecting portal hypertension: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. https://doi.org/10.1097/meg.0000000000001724CrossRefPubMed

96.

Arena U, Lupsor Platon M, Stasi C, Moscarella S, Assarat A, Bedogni G, Piazzolla V, Badea R, Laffi G, Marra F, Mangia A, Pinzani M (2013) Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution. Hepatology 58 (1):65-72. https://doi.org/10.1002/hep.26343CrossRefPubMed

97.

Berzigotti A, Gottardi AD, Vukotic R, Siramolpiwat S, Abraldes JG, García-Pagan JC, Bosch J (2013) Effect of Meal Ingestion on Liver Stiffness in Patients with Cirrhosis and Portal Hypertension. PLOS ONE 8 (3):e58742. https://doi.org/10.1371/journal.pone.0058742CrossRefPubMedPubMedCentral

98.

Hines CDG, Lindstrom MJ, Varma AK, Reeder SB (2011) Effects of postprandial state and mesenteric blood flow on the repeatability of MR elastography in asymptomatic subjects. J Magn Reson Imaging 33 (1):239-244. https://doi.org/10.1002/jmri.22354CrossRefPubMed

99.

Jajamovich GH, Dyvorne H, Donnerhack C, Taouli B (2014) Quantitative Liver MRI Combining Phase Contrast Imaging, Elastography, and DWI: Assessment of Reproducibility and Postprandial Effect at 3.0 T. PLoS ONE 9 (5). https://doi.org/10.1371/journal.pone.0097355

100.

Mederacke I, Wursthorn K, Kirschner J, Rifai K, Manns MP, Wedemeyer H, Bahr MJ (2009) Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection. Liver International 29 (10):1500-1506. https://doi.org/10.1111/j.1478-3231.2009.02100.xCrossRefPubMed

101.

Popescu A, Bota S, Sporea I, Sirli R, Danila M, Racean S, Suseanu D, Gradinaru O, Ivascu Siegfried C (2013) The Influence of Food Intake on Liver Stiffness Values Assessed by Acoustic Radiation Force Impulse Elastography—Preliminary Results. Ultrasound in Medicine & Biology 39 (4):579-584. https://doi.org/10.1016/j.ultrasmedbio.2012.11.013CrossRef

102.

Yin M, Talwalkar JA, Glaser KJ, Venkatesh SK, Chen J, Manduca A, Ehman RL (2011) Dynamic Postprandial Hepatic Stiffness Augmentation Assessed With MR Elastography in Patients With Chronic Liver Disease. American Journal of Roentgenology 197 (1):64-70. https://doi.org/10.2214/ajr.10.5989CrossRefPubMed

103.

Arena U, Vizzutti F, Corti G, Ambu S, Stasi C, Bresci S, Moscarella S, Boddi V, Petrarca A, Laffi G, Marra F, Pinzani M (2008) Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 47 (2):380-384. https://doi.org/10.1002/hep.22007CrossRefPubMed

104.

Coco B, Oliveri F, Maina AM, Ciccorossi P, Sacco R, Colombatto P, Bonino F, Brunetto MR (2007) Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. Journal of Viral Hepatitis 14 (5):360-369. https://doi.org/10.1111/j.1365-2893.2006.00811.xCrossRefPubMed

105.

Sagir A, Erhardt A, Schmitt M, Häussinger D (2008) Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 47 (2):592-595. https://doi.org/10.1002/hep.22056CrossRefPubMed

106.

Millonig G, Reimann FM, Friedrich S, Fonouni H, Mehrabi A, Büchler MW, Seitz HK, Mueller S (2008) Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology 48 (5):1718-1723. https://doi.org/10.1002/hep.22577CrossRefPubMed

107.

Pfeifer L, Strobel D, Neurath MF, Wildner D (2014) Liver stiffness assessed by acoustic radiation force impulse (ARFI) technology is considerably increased in patients with cholestasis. Ultraschall in Der Medizin (Stuttgart, Germany: 1980) 35 (4):364-367. https://doi.org/10.1055/s-0034-1366057

108.

Eaton JE, Dzyubak B, Venkatesh SK, Smyrk TC, Gores GJ, Ehman RL, LaRusso NF, Gossard AA, Lazaridis KN (2016) Performance of magnetic resonance elastography in primary sclerosing cholangitis. Journal of Gastroenterology and Hepatology 31 (6):1184-1190. https://doi.org/10.1111/jgh.13263CrossRefPubMedPubMedCentral

109.

Berzigotti A (2017) Non-invasive evaluation of portal hypertension using ultrasound elastography. J Hepatol 67 (2):399-411. https://doi.org/10.1016/j.jhep.2017.02.003CrossRefPubMed

110.

Reiberger T, Ferlitsch A, Payer BA, Pinter M, Homoncik M, Peck-Radosavljevic M, Vienna Hepatic Hemodynamic L (2012) Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis. Journal of Gastroenterology 47 (5):561-568. https://doi.org/10.1007/s00535-011-0517-4CrossRefPubMed

111.

Castera L, Foucher J, Bernard PH, Carvalho F, Allaix D, Merrouche W, Couzigou P, de Ledinghen V (2010) Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 51 (3):828-835. https://doi.org/10.1002/hep.23425CrossRefPubMed

112.

de Ledinghen V, Wong VW, Vergniol J, Wong GL, Foucher J, Chu SH, Le Bail B, Choi PC, Chermak F, Yiu KK, Merrouche W, Chan HL (2012) Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan(R). J Hepatol 56 (4):833-839. https://doi.org/10.1016/j.jhep.2011.10.017CrossRefPubMed

113.

Bota S, Herkner H, Sporea I, Salzl P, Sirli R, Neghina AM, Peck-Radosavljevic M (2013) Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis. Liver Int 33 (8):1138-1147. https://doi.org/10.1111/liv.12240CrossRefPubMed

114.

Sporea I, Bota S, Gradinaru-Tascau O, Sirli R, Popescu A, Jurchis A (2014) Which are the cut-off values of 2D-Shear Wave Elastography (2D-SWE) liver stiffness measurements predicting different stages of liver fibrosis, considering Transient Elastography (TE) as the reference method? Eur J Radiol 83 (3):e118-122. https://doi.org/10.1016/j.ejrad.2013.12.011CrossRefPubMed

115.

Wagner M, Corcuera-Solano I, Lo G, Esses S, Liao J, Besa C, Chen N, Abraham G, Fung M, Babb JS, Ehman RL, Taouli B (2017) Technical Failure of MR Elastography Examinations of the Liver: Experience from a Large Single-Center Study. Radiology 284 (2):401-412. https://doi.org/10.1148/radiol.2016160863CrossRefPubMed

116.

Wagner M, Besa C, Bou Ayache J, Yasar TK, Bane O, Fung M, Ehman RL, Taouli B (2016) Magnetic Resonance Elastography of the Liver: Qualitative and Quantitative Comparison of Gradient Echo and Spin Echo Echoplanar Imaging Sequences. Invest Radiol 51 (9):575-581. https://doi.org/10.1097/rli.0000000000000269CrossRefPubMedPubMedCentral

117.

Burkart DJ, Johnson CD, Morton MJ, Wolf RL, Ehman RL (1993) Volumetric flow rates in the portal venous system: measurement with cine phase-contrast MR imaging. AJR Am J Roentgenol 160 (5):1113-1118. https://doi.org/10.2214/ajr.160.5.8470589CrossRefPubMed

118.

Gouya H, Vignaux O, Sogni P, Mallet V, Oudjit A, Pol S, Legmann P (2011) Chronic liver disease: systemic and splanchnic venous flow mapping with optimized cine phase-contrast MR imaging validated in a phantom model and prospectively evaluated in patients. Radiology 261 (1):144-155. https://doi.org/10.1148/radiol.11101541CrossRefPubMed

119.

Hara AK, Burkart DJ, Johnson CD, Felmlee JP, Ehman RL, Ilstrup DM, Harmsen WS (1996) Variability of consecutive in vivo MR flow measurements in the main portal vein. AJR Am J Roentgenol 166 (6):1311-1315. https://doi.org/10.2214/ajr.166.6.8633438CrossRefPubMed

120.

Yzet T, Bouzerar R, Allart JD, Demuynck F, Legallais C, Robert B, Deramond H, Meyer ME, Balédent O (2010) Hepatic vascular flow measurements by phase contrast MRI and doppler echography: a comparative and reproducibility study. J Magn Reson Imaging 31 (3):579-588. https://doi.org/10.1002/jmri.22079CrossRefPubMed

121.

Jajamovich GH, Dyvorne H, Donnerhack C, Taouli B (2014) Quantitative liver MRI combining phase contrast imaging, elastography, and DWI: assessment of reproducibility and postprandial effect at 3.0 T. PLoS One 9 (5):e97355. https://doi.org/10.1371/journal.pone.0097355

122.

Soulat G, McCarthy P, Markl M (2020) 4D Flow with MRI. Annu Rev Biomed Eng. https://doi.org/10.1146/annurev-bioeng-100219-110055CrossRefPubMed

123.

Stankovic Z (2016) Four-dimensional flow magnetic resonance imaging in cirrhosis. World J Gastroenterol 22 (1):89-102. https://doi.org/10.3748/wjg.v22.i1.89CrossRefPubMedPubMedCentral

124.

Chouhan MD, Mookerjee RP, Bainbridge A, Punwani S, Jones H, Davies N, Walker-Samuel S, Patch D, Jalan R, Halligan S, Lythgoe MF, Taylor SA (2017) Caval Subtraction 2D Phase-Contrast MRI to Measure Total Liver and Hepatic Arterial Blood Flow: Proof-of-Principle, Correlation With Portal Hypertension Severity and Validation in Patients With Chronic Liver Disease. Invest Radiol 52 (3):170-176. https://doi.org/10.1097/rli.0000000000000328CrossRefPubMed

125.

Gouya H, Grabar S, Vignaux O, Saade A, Pol S, Legmann P, Sogni P (2016) Portal hypertension in patients with cirrhosis: indirect assessment of hepatic venous pressure gradient by measuring azygos flow with 2D-cine phase-contrast magnetic resonance imaging. Eur Radiol 26 (7):1981-1990. https://doi.org/10.1007/s00330-015-3991-xCrossRefPubMed

126.

McAvoy NC, Semple S, Richards JM, Robson AJ, Patel D, Jardine AG, Leyland K, Cooper AS, Newby DE, Hayes PC (2016) Differential visceral blood flow in the hyperdynamic circulation of patients with liver cirrhosis. Aliment Pharmacol Ther 43 (9):947-954. https://doi.org/10.1111/apt.13571CrossRefPubMed

127.

McDonald N, Lilburn DML, Lachlan NJ, Macnaught G, Patel D, Jayaswal ANA, Hayes PC, Semple SI, Fallowfield JA (2017) Assessment of Haemodynamic Response to Nonselective Beta-Blockers in Portal Hypertension by Phase-Contrast Magnetic Resonance Angiography. Biomed Res Int 2017:9281450. https://doi.org/10.1155/2017/9281450CrossRefPubMedPubMedCentral

128.

Palaniyappan N, Cox E, Bradley C, Scott R, Austin A, O’Neill R, Ramjas G, Travis S, White H, Singh R, Thurley P, Guha IN, Francis S, Aithal GP (2016) Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging. J Hepatol 65 (6):1131-1139. https://doi.org/10.1016/j.jhep.2016.07.021CrossRefPubMedPubMedCentral

129.

Villa G, Ringgaard S, Hermann I, Noble R, Brambilla P, Khatir DS, Zollner FG, Francis ST, Selby NM, Remuzzi A, Caroli A (2020) Phase-contrast magnetic resonance imaging to assess renal perfusion: a systematic review and statement paper. MAGMA 33 (1):3-21. https://doi.org/10.1007/s10334-019-00772-0CrossRefPubMed

130.

Dyvorne H, Knight-Greenfield A, Jajamovich G, Besa C, Cui Y, Stalder A, Markl M, Taouli B (2015) Abdominal 4D flow MR imaging in a breath hold: combination of spiral sampling and dynamic compressed sensing for highly accelerated acquisition. Radiology 275 (1):245-254. https://doi.org/10.1148/radiol.14140973CrossRefPubMed

131.

van Ooij P, Powell AL, Potters WV, Carr JC, Markl M, Barker AJ (2016) Reproducibility and interobserver variability of systolic blood flow velocity and 3D wall shear stress derived from 4D flow MRI in the healthy aorta. J Magn Reson Imaging 43 (1):236-248. https://doi.org/10.1002/jmri.24959CrossRefPubMed

132.

Saitta S, Pirola S, Piatti F, Votta E, Lucherini F, Pluchinotta F, Carminati M, Lombardi M, Geppert C, Cuomo F, Figueroa CA, Xu XY, Redaelli A (2019) Evaluation of 4D flow MRI-based non-invasive pressure assessment in aortic coarctations. J Biomech 94:13-21. https://doi.org/10.1016/j.jbiomech.2019.07.004CrossRefPubMed

133.

Bannas P, Roldan-Alzate A, Johnson KM, Woods MA, Ozkan O, Motosugi U, Wieben O, Reeder SB, Kramer H (2016) Longitudinal Monitoring of Hepatic Blood Flow before and after TIPS by Using 4D-Flow MR Imaging. Radiology 281 (2):574-582. https://doi.org/10.1148/radiol.2016152247CrossRefPubMed

134.

Frydrychowicz A, Roldan-Alzate A, Winslow E, Consigny D, Campo CA, Motosugi U, Johnson KM, Wieben O, Reeder SB (2017) Comparison of radial 4D Flow-MRI with perivascular ultrasound to quantify blood flow in the abdomen and introduction of a porcine model of pre-hepatic portal hypertension. Eur Radiol. https://doi.org/10.1007/s00330-017-4862-4CrossRefPubMedPubMedCentral

135.

Roldan-Alzate A, Frydrychowicz A, Niespodzany E, Landgraf BR, Johnson KM, Wieben O, Reeder SB (2013) In vivo validation of 4D flow MRI for assessing the hemodynamics of portal hypertension. J Magn Reson Imaging 37 (5):1100-1108. https://doi.org/10.1002/jmri.23906CrossRefPubMed

136.

Roldan-Alzate A, Frydrychowicz A, Said A, Johnson KM, Francois CJ, Wieben O, Reeder SB (2015) Impaired regulation of portal venous flow in response to a meal challenge as quantified by 4D flow MRI. J Magn Reson Imaging 42 (4):1009-1017. https://doi.org/10.1002/jmri.24886CrossRefPubMedPubMedCentral

137.

Stankovic Z, Csatari Z, Deibert P, Euringer W, Blanke P, Kreisel W, Abdullah Zadeh Z, Kallfass F, Langer M, Markl M (2012) Normal and altered three-dimensional portal venous hemodynamics in patients with liver cirrhosis. Radiology 262 (3):862-873. https://doi.org/10.1148/radiol.11110127CrossRefPubMed

138.

Stankovic Z, Csatari Z, Deibert P, Euringer W, Jung B, Kreisel W, Geiger J, Russe MF, Langer M, Markl M (2013) A feasibility study to evaluate splanchnic arterial and venous hemodynamics by flow-sensitive 4D MRI compared with Doppler ultrasound in patients with cirrhosis and controls. Eur J Gastroenterol Hepatol 25 (6):669-675. https://doi.org/10.1097/meg.0b013e32835e1297CrossRefPubMed

139.

Stankovic Z, Frydrychowicz A, Csatari Z, Panther E, Deibert P, Euringer W, Kreisel W, Russe M, Bauer S, Langer M, Markl M (2010) MR-based visualization and quantification of three-dimensional flow characteristics in the portal venous system. J Magn Reson Imaging 32 (2):466-475. https://doi.org/10.1002/jmri.22248CrossRefPubMed

140.

Motosugi U, Roldan-Alzate A, Bannas P, Said A, Kelly S, Zea R, Wieben O, Reeder SB (2019) Four-dimensional Flow MRI as a Marker for Risk Stratification of Gastroesophageal Varices in Patients with Liver Cirrhosis. Radiology 290 (1):101-107. https://doi.org/10.1148/radiol.2018180230CrossRefPubMed

141.

Frydrychowicz A, Landgraf BR, Niespodzany E, Verma RW, Roldan-Alzate A, Johnson KM, Wieben O, Reeder SB (2011) Four-dimensional velocity mapping of the hepatic and splanchnic vasculature with radial sampling at 3 tesla: a feasibility study in portal hypertension. J Magn Reson Imaging 34 (3):577-584. https://doi.org/10.1002/jmri.22712CrossRefPubMedPubMedCentral

142.

Bane O, Peti S, Wagner M, Hectors S, Dyvorne H, Markl M, Taouli B (2019) Hemodynamic measurements with an abdominal 4D flow MRI sequence with spiral sampling and compressed sensing in patients with chronic liver disease. J Magn Reson Imaging 49 (4):994-1005. https://doi.org/10.1002/jmri.26305CrossRefPubMed

143.

Bollache E, Barker AJ, Dolan RS, Carr JC, van Ooij P, Ahmadian R, Powell A, Collins JD, Geiger J, Markl M (2018) k-t accelerated aortic 4D flow MRI in under two minutes: Feasibility and impact of resolution, k-space sampling patterns, and respiratory navigator gating on hemodynamic measurements. Magn Reson Med 79 (1):195-207. https://doi.org/10.1002/mrm.26661CrossRefPubMed

144.

Gulberg V, Haag K, Rossle M, Gerbes AL (2002) Hepatic arterial buffer response in patients with advanced cirrhosis. Hepatology 35 (3):630-634. https://doi.org/10.1053/jhep.2002.31722CrossRefPubMed

145.

Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE (2003) Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 229 (2):409-414. https://doi.org/10.1148/radiol.2292021128CrossRefPubMed

146.

Dyvorne HA, Jajamovich GH, Bane O, Fiel MI, Chou H, Schiano TD, Dieterich D, Babb JS, Friedman SL, Taouli B (2016) Prospective comparison of magnetic resonance imaging to transient elastography and serum markers for liver fibrosis detection. Liver Int 36 (5):659-666. https://doi.org/10.1111/liv.13058CrossRefPubMedPubMedCentral

147.

Wagner M, Hectors S, Bane O, Gordic S, Kennedy P, Besa C, Schiano TD, Thung S, Fischman A, Taouli B (2018) Noninvasive prediction of portal pressure with MR elastography and DCE-MRI of the liver and spleen: Preliminary results. J Magn Reson Imaging 48 (4):1091-1103. https://doi.org/10.1002/jmri.26026CrossRefPubMedPubMedCentral

148.

Costa AF, van der Pol CB, Maralani PJ, McInnes MDF, Shewchuk JR, Verma R, Hurrell C, Schieda N (2018) Gadolinium Deposition in the Brain: A Systematic Review of Existing Guidelines and Policy Statement Issued by the Canadian Association of Radiologists. Can Assoc Radiol J 69 (4):373-382. https://doi.org/10.1016/j.carj.2018.04.002CrossRefPubMed

149.

Lord ML, McNeill FE, Grafe JL, Noseworthy MD, Chettle DR (2018) Self-identified gadolinium toxicity: comparison of gadolinium in bone and urine to healthy gadolinium-based contrast agent exposed volunteers. Physiol Meas 39 (11):115008. https://doi.org/10.1088/1361-6579/aaedc6CrossRefPubMed

150.

Damme NM, Fernandez DP, Wang LM, Wu Q, Kirk RA, Towner RA, McNally JS, Hoffman JM, Morton KA (2020) Analysis of retention of gadolinium by brain, bone, and blood following linear gadolinium-based contrast agent administration in rats with experimental sepsis. Magn Reson Med 83 (6):1930-1939. https://doi.org/10.1002/mrm.28060CrossRefPubMed

151.

Stanescu AL, Shaw DW, Murata N, Murata K, Rutledge JC, Maloney E, Maravilla KR (2020) Brain tissue gadolinium retention in pediatric patients after contrast-enhanced magnetic resonance exams: pathological confirmation. Pediatr Radiol 50 (3):388-396. https://doi.org/10.1007/s00247-019-04535-wCrossRefPubMed

152.

Talakic E, Schaffellner S, Kniepeiss D, Mueller H, Stauber R, Quehenberger F, Schoellnast H (2017) CT perfusion imaging of the liver and the spleen in patients with cirrhosis: Is there a correlation between perfusion and portal venous hypertension? Eur Radiol 27 (10):4173-4180. https://doi.org/10.1007/s00330-017-4788-xCrossRefPubMedPubMedCentral

153.

Tsushima Y, Koizumi J, Yokoyama H, Takeda A, Kusano S (1998) Evaluation of portal pressure by splenic perfusion measurement using dynamic CT. AJR Am J Roentgenol 170 (1):153-155. https://doi.org/10.2214/ajr.170.1.9423623CrossRefPubMed

154.

Asenbaum U, Ba-Ssalamah A, Mandorfer M, Nolz R, Furtner J, Reiberger T, Ferlitsch A, Kaczirek K, Trauner M, Peck-Radosavljevic M, Wibmer AG (2017) Effects of Portal Hypertension on Gadoxetic Acid-Enhanced Liver Magnetic Resonance: Diagnostic and Prognostic Implications. Invest Radiol 52 (8):462-469. https://doi.org/10.1097/rli.0000000000000366CrossRefPubMed

155.

Bane O, Hectors SJ, Wagner M, Arlinghaus LL, Aryal MP, Cao Y, Chenevert TL, Fennessy F, Huang W, Hylton NM, Kalpathy-Cramer J, Keenan KE, Malyarenko DI, Mulkern RV, Newitt DC, Russek SE, Stupic KF, Tudorica A, Wilmes LJ, Yankeelov TE, Yen YF, Boss MA, Taouli B (2018) Accuracy, repeatability, and interplatform reproducibility of T1 quantification methods used for DCE-MRI: Results from a multicenter phantom study. Magn Reson Med 79 (5):2564-2575. https://doi.org/10.1002/mrm.26903CrossRefPubMed

156.

Dekkers IA, Lamb HJ (2018) Clinical application and technical considerations of T1 & T2(*) mapping in cardiac, liver, and renal imaging. Br J Radiol 91 (1092):20170825. https://doi.org/10.1259/bjr.20170825CrossRefPubMedPubMedCentral

157.

Besa C, Bane O, Jajamovich G, Marchione J, Taouli B (2015) 3D T1 relaxometry pre and post gadoxetic acid injection for the assessment of liver cirrhosis and liver function. Magn Reson Imaging 33 (9):1075-1082. https://doi.org/10.1016/j.mri.2015.06.013CrossRefPubMed

158.

Luetkens JA, Klein S, Traber F, Schmeel FC, Sprinkart AM, Kuetting DLR, Block W, Uschner FE, Schierwagen R, Hittatiya K, Kristiansen G, Gieseke J, Schild HH, Trebicka J, Kukuk GM (2018) Quantification of Liver Fibrosis at T1 and T2 Mapping with Extracellular Volume Fraction MRI: Preclinical Results. Radiology 288 (3):748-754. https://doi.org/10.1148/radiol.2018180051CrossRefPubMed

159.

Bachtiar V, Kelly MD, Wilman HR, Jacobs J, Newbould R, Kelly CJ, Gyngell ML, Groves KE, McKay A, Herlihy AH, Fernandes CC, Halberstadt M, Maguire M, Jayaratne N, Linden S, Neubauer S, Banerjee R (2019) Repeatability and reproducibility of multiparametric magnetic resonance imaging of the liver. PLoS One 14 (4):e0214921. https://doi.org/10.1371/journal.pone.0214921CrossRefPubMedPubMedCentral

160.

Banerjee R, Pavlides M, Tunnicliffe EM, Piechnik SK, Sarania N, Philips R, Collier JD, Booth JC, Schneider JE, Wang LM, Delaney DW, Fleming KA, Robson MD, Barnes E, Neubauer S (2014) Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J Hepatol 60 (1):69-77. https://doi.org/10.1016/j.jhep.2013.09.002CrossRefPubMedPubMedCentral

161.

Pavlides M, Banerjee R, Sellwood J, Kelly CJ, Robson MD, Booth JC, Collier J, Neubauer S, Barnes E (2016) Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease. J Hepatol 64 (2):308-315. https://doi.org/10.1016/j.jhep.2015.10.009CrossRefPubMedPubMedCentral

162.

Dillman JR, Serai SD, Trout AT, Singh R, Tkach JA, Taylor AE, Blaxall BC, Fei L, Miethke AG (2019) Diagnostic performance of quantitative magnetic resonance imaging biomarkers for predicting portal hypertension in children and young adults with autoimmune liver disease. Pediatr Radiol 49 (3):332-341. https://doi.org/10.1007/s00247-018-4319-1CrossRefPubMedPubMedCentral

163.

Hoffman DH, Ayoola A, Nickel D, Han F, Chandarana H, Babb J, Shanbhogue KP (2020) MR elastography, T1 and T2 relaxometry of liver: role in noninvasive assessment of liver function and portal hypertension. Abdom Radiol (NY). https://doi.org/10.1007/s00261-020-02432-7CrossRef

164.

Wood JC, Enriquez C, Ghugre N, Tyzka JM, Carson S, Nelson MD, Coates TD (2005) MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 106 (4):1460-1465. https://doi.org/10.1182/blood-2004-10-3982CrossRefPubMedPubMedCentral

165.

Hectors SJ, Bane O, Stocker D, Carbonell G, Lewis S, Kennedy P, Schiano TD, Thung S, Fischman A, Taouli B (2020) Splenic T1rho as a noninvasive biomarker for portal hypertension. J Magn Reson Imaging. https://doi.org/10.1002/jmri.27087CrossRefPubMed

166.

Rosenkrantz AB, Storey P, Gilet AG, Niver BE, Babb JS, Hajdu CH, Lee VS (2012) Magnetization transfer contrast-prepared MR imaging of the liver: inability to distinguish healthy from cirrhotic liver. Radiology 262 (1):136-143. https://doi.org/10.1148/radiol.11111043CrossRefPubMed

167.

Singh A, Reddy D, Haris M, Cai K, Rajender Reddy K, Hariharan H, Reddy R (2015) T1rho MRI of healthy and fibrotic human livers at 1.5 T. J Transl Med 13:292. https://doi.org/10.1186/s12967-015-0648-0

168.

Hectors SJ, Bane O, Kennedy P, El Salem F, Menon M, Segall M, Khaim R, Delaney V, Lewis S, Taouli B (2019) T1rho mapping for assessment of renal allograft fibrosis. J Magn Reson Imaging 50 (4):1085-1091. https://doi.org/10.1002/jmri.26656CrossRefPubMed

169.

Yoon JH, Lee JM, Paek M, Han JK, Choi BI (2016) Quantitative assessment of hepatic function: modified look-locker inversion recovery (MOLLI) sequence for T1 mapping on Gd-EOB-DTPA-enhanced liver MR imaging. Eur Radiol 26 (6):1775-1782. https://doi.org/10.1007/s00330-015-3994-7CrossRefPubMed

170.

Levick C, Phillips-Hughes J, Collier J, Banerjee R, Cobbold JF, Wang LM, Piechnik SK, Robson MD, Neubauer S, Barnes E, Pavlides M (2019) Non-invasive assessment of portal hypertension by multi-parametric magnetic resonance imaging of the spleen: A proof of concept study. PLoS One 14 (8):e0221066. https://doi.org/10.1371/journal.pone.0221066CrossRefPubMedPubMedCentral

171.

Takayama Y, Nishie A, Asayama Y, Ushijima Y, Okamoto D, Fujita N, Morita K, Shirabe K, Kotoh K, Kubo Y, Okuaki T, Honda H (2015) T1 rho Relaxation of the liver: A potential biomarker of liver function. J Magn Reson Imaging 42 (1):188-195. https://doi.org/10.1002/jmri.24739CrossRefPubMed

172.

Bolognesi M, Merkel C, Sacerdoti D, Nava V, Gatta A (2002) Role of spleen enlargement in cirrhosis with portal hypertension. Dig Liver Dis 34 (2):144-150. https://doi.org/10.1016/s1590-8658(02)80246-8CrossRefPubMed

173.

Piecha F, Mandorfer M, Peccerella T, Ozga AK, Poth T, Vonbank A, Seitz HK, Rausch V, Reiberger T, Mueller S (2018) Pharmacological decrease of liver stiffness is pressure-related and predicts long-term clinical outcome. Am J Physiol Gastrointest Liver Physiol 315 (4):G484-G494. https://doi.org/10.1152/ajpgi.00392.2017CrossRefPubMed

174.

Piyachaturawat P, Siramolpiwat S, Sonsiri K, Tangkijvanich P, Treeprasertsuk S (2018) Changes in transient elastography in early cirrhotic patients after receiving nonselective B-blocker for primary variceal bleeding prophylaxis: Three-month follow up. JGH Open 2 (5):172-177. https://doi.org/10.1002/jgh3.12063CrossRefPubMedPubMedCentral

175.

Buechter M, Manka P, Theysohn JM, Reinboldt M, Canbay A, Kahraman A (2018) Spleen stiffness is positively correlated with HVPG and decreases significantly after TIPS implantation. Dig Liver Dis 50 (1):54-60. https://doi.org/10.1016/j.dld.2017.09.138CrossRefPubMed

176.

Jansen C, Moller P, Meyer C, Kolbe CC, Bogs C, Pohlmann A, Schierwagen R, Praktiknjo M, Abdullah Z, Lehmann J, Thomas D, Strassburg CP, Latz E, Mueller S, Rossle M, Trebicka J (2018) Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortality. Hepatology 67 (4):1472-1484. https://doi.org/10.1002/hep.29612CrossRefPubMed

177.

De Santis A, Nardelli S, Bassanelli C, Lupo M, Iegri C, Di Ciesco CA, Forlino M, Farcomeni A, Riggio O (2018) Modification of splenic stiffness on acoustic radiation force impulse parallels the variation of portal pressure induced by transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol 33 (3):704-709. https://doi.org/10.1111/jgh.13907CrossRefPubMed

178.

Gao J, Ran HT, Ye XP, Zheng YY, Zhang DZ, Wang ZG (2012) The stiffness of the liver and spleen on ARFI Imaging pre and post TIPS placement: a preliminary observation. Clin Imaging 36 (2):135-141. https://doi.org/10.1016/j.clinimag.2011.11.014CrossRefPubMed

179.

Hirsch S, Guo J, Reiter R, Schott E, Buning C, Somasundaram R, Braun J, Sack I, Kroencke TJ (2014) Towards compression-sensitive magnetic resonance elastography of the liver: sensitivity of harmonic volumetric strain to portal hypertension. J Magn Reson Imaging 39 (2):298-306. https://doi.org/10.1002/jmri.24165CrossRefPubMed

180.

Wang HW, Shi HN, Cheng J, Xie F, Luo YK, Tang J (2018) Real-time shear wave elastography (SWE) assessment of short- and long-term treatment outcome in Budd-Chiari syndrome: A pilot study. PLoS One 13 (5):e0197550. https://doi.org/10.1371/journal.pone.0197550CrossRefPubMedPubMedCentral

181.

Stankovic Z, Rossle M, Euringer W, Schultheiss M, Salem R, Barker A, Carr J, Langer M, Markl M, Collins JD (2015) Effect of TIPS placement on portal and splanchnic arterial blood flow in 4-dimensional flow MRI. Eur Radiol 25 (9):2634-2640. https://doi.org/10.1007/s00330-015-3663-xCrossRefPubMed

182.

Foshager MC, Ferral H, Nazarian GK, Castañeda-Zúñiga WR, Letourneau JG (1995) Duplex sonography after transjugular intrahepatic portosystemic shunts (TIPS): normal hemodynamic findings and efficacy in predicting shunt patency and stenosis. AJR Am J Roentgenol 165 (1):1-7. https://doi.org/10.2214/ajr.165.1.7785564CrossRefPubMed

183.

Farrar CT, Gale EM, Kennan R, Ramsay I, Masia R, Arora G, Looby K, Wei L, Kalpathy-Cramer J, Bunzel MM, Zhang C, Zhu Y, Akiyama TE, Klimas M, Pinto S, Diyabalanage H, Tanabe KK, Humblet V, Fuchs BC, Caravan P (2018) CM-101: Type I Collagen-targeted MR Imaging Probe for Detection of Liver Fibrosis. Radiology 287 (2):581-589. https://doi.org/10.1148/radiol.2017170595CrossRefPubMed

184.

Salarian M, Turaga RC, Xue S, Nezafati M, Hekmatyar K, Qiao J, Zhang Y, Tan S, Ibhagui OY, Hai Y, Li J, Mukkavilli R, Sharma M, Mittal P, Min X, Keilholz S, Yu L, Qin G, Farris AB, Liu ZR, Yang JJ (2019) Early detection and staging of chronic liver diseases with a protein MRI contrast agent. Nat Commun 10 (1):4777. https://doi.org/10.1038/s41467-019-11984-2CrossRefPubMedPubMedCentral

185.

Berhane H, Scott M, Elbaz M, Jarvis K, McCarthy P, Carr J, Malaisrie C, Avery R, Barker AJ, Robinson JD, Rigsby CK, Markl M (2020) Fully automated 3D aortic segmentation of 4D flow MRI for hemodynamic analysis using deep learning. Magn Reson Med. https://doi.org/10.1002/mrm.28257CrossRefPubMedPubMedCentral

186.

Weiss J, Ruff C, Grosse U, Grozinger G, Horger M, Nikolaou K, Gatidis S (2019) Assessment of Hepatic Perfusion Using GRASP MRI: Bringing Liver MRI on a New Level. Invest Radiol 54 (12):737-743. https://doi.org/10.1097/rli.0000000000000586CrossRefPubMed

187.

Feng L, Huang C, Shanbhogue K, Sodickson DK, Chandarana H, Otazo R (2018) RACER-GRASP: Respiratory-weighted, aortic contrast enhancement-guided and coil-unstreaking golden-angle radial sparse MRI. Magn Reson Med 80 (1):77-89. https://doi.org/10.1002/mrm.27002CrossRefPubMed

188.

Chandarana H, Feng L, Ream J, Wang A, Babb JS, Block KT, Sodickson DK, Otazo R (2015) Respiratory Motion-Resolved Compressed Sensing Reconstruction of Free-Breathing Radial Acquisition for Dynamic Liver Magnetic Resonance Imaging. Invest Radiol 50 (11):749-756. https://doi.org/10.1097/rli.0000000000000179CrossRefPubMedPubMedCentral

189.

Chandarana H, Feng L, Block TK, Rosenkrantz AB, Lim RP, Babb JS, Sodickson DK, Otazo R (2013) Free-breathing contrast-enhanced multiphase MRI of the liver using a combination of compressed sensing, parallel imaging, and golden-angle radial sampling. Invest Radiol 48 (1):10-16. https://doi.org/10.1097/rli.0b013e318271869cCrossRefPubMedPubMedCentral

190.

Gu Y, Wang CY, Anderson CE, Liu Y, Hu H, Johansen ML, Ma D, Jiang Y, Ramos-Estebanez C, Brady-Kalnay S, Griswold MA, Flask CA, Yu X (2018) Fast magnetic resonance fingerprinting for dynamic contrast-enhanced studies in mice. Magn Reson Med 80 (6):2681-2690. https://doi.org/10.1002/mrm.27345CrossRefPubMedPubMedCentral

191.

Sourbron S, Sommer WH, Reiser MF, Zech CJ (2012) Combined quantification of liver perfusion and function with dynamic gadoxetic acid-enhanced MR imaging. Radiology 263 (3):874-883. https://doi.org/10.1148/radiol.12110337CrossRefPubMed

192.

Liu F, Ning Z, Liu Y, Liu D, Tian J, Luo H, An W, Huang Y, Zou J, Liu C, Liu C, Wang L, Liu Z, Qi R, Zuo C, Zhang Q, Wang J, Zhao D, Duan Y, Peng B, Qi X, Zhang Y, Yang Y, Hou J, Dong J, Li Z, Ding H, Zhang Y, Qi X (2018) Development and validation of a radiomics signature for clinically significant portal hypertension in cirrhosis (CHESS1701): a prospective multicenter study. EBioMedicine 36:151-158. https://doi.org/10.1016/j.ebiom.2018.09.023CrossRefPubMedPubMedCentral

193.

Tseng Y, Ma L, Li S, Luo T, Luo J, Zhang W, Wang J, Chen S (2020) Application of CT-based radiomics in predicting portal pressure and patient outcome in portal hypertension. Eur J Radiol 126:108927. https://doi.org/10.1016/j.ejrad.2020.108927CrossRefPubMed

194.

Liu Y, Ning Z, Ormeci N, An W, Yu Q, Han K, Huang Y, Liu D, Liu F, Li Z, Ding H, Luo H, Zuo C, Liu C, Wang J, Zhang C, Ji J, Wang W, Wang Z, Wang W, Yuan M, Li L, Zhao Z, Wang G, Li M, Liu Q, Lei J, Liu C, Tang T, Akcalar S, Celebioglu E, Ustuner E, Bilgic S, Ellik Z, Asiller OO, Liu Z, Teng G, Chen Y, Hou J, Li X, He X, Dong J, Tian J, Liang P, Ju S, Zhang Y, Qi X (2020) Deep Convolutional Neural Network-aided Detection of Portal Hypertension in Patients With Cirrhosis. Clin Gastroenterol Hepatol. https://doi.org/10.1016/j.cgh.2020.03.034CrossRefPubMedPubMedCentral

195.

Vizzutti F, Arena U, Romanelli RG, Rega L, Foschi M, Colagrande S, Petrarca A, Moscarella S, Belli G, Zignego AL, Marra F, Laffi G, Pinzani M (2007) Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 45 (5):1290-1297. https://doi.org/10.1002/hep.21665CrossRefPubMed

196.

Bureau C, Metivier S, Peron JM, Selves J, Robic MA, Gourraud PA, Rouquet O, Dupuis E, Alric L, Vinel JP (2008) Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther 27 (12):1261-1268. https://doi.org/10.1111/j.1365-2036.2008.03701.xCrossRefPubMed

197.

Lemoine M, Katsahian S, Ziol M, Nahon P, Ganne-Carrie N, Kazemi F, Grando-Lemaire V, Trinchet JC, Beaugrand M (2008) Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. Aliment Pharmacol Ther 28 (9):1102-1110. https://doi.org/10.1111/j.1365-2036.2008.03825.xCrossRefPubMed

198.

Sanchez-Conde M, Miralles P, Bellon JM, Rincon D, Ramirez M, Gutierrez I, Ripoll C, Lopez JC, Cosin J, Clemente G, Lo Iacono O, Banares R, Berenguer J (2011) Use of transient elastography (FibroScan(R)) for the noninvasive assessment of portal hypertension in HIV/HCV-coinfected patients. J Viral Hepat 18 (10):685-691. https://doi.org/10.1111/j.1365-2893.2010.01371.xCrossRefPubMed

199.

Llop E, Berzigotti A, Reig M, Erice E, Reverter E, Seijo S, Abraldes JG, Bruix J, Bosch J, Garcia-Pagan JC (2012) Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors. J Hepatol 56 (1):103-108. https://doi.org/10.1016/j.jhep.2011.06.027CrossRefPubMed

200.

Reiberger T, Ferlitsch A, Payer BA, Pinter M, Schwabl P, Stift J, Trauner M, Peck-Radosavljevic M (2012) Noninvasive screening for liver fibrosis and portal hypertension by transient elastography—a large single center experience. Wien Klin Wochenschr 124 (11):395-402. https://doi.org/10.1007/s00508-012-0190-5CrossRefPubMed

201.

Hong WK, Kim MY, Baik SK, Shin SY, Kim JM, Kang YS, Lim YL, Kim YJ, Cho YZ, Hwang HW, Lee JH, Chae MH, Kim HA, Kang HW, Kwon SO (2013) The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data. Clinical and Molecular Hepatology 19 (4):370-375. https://doi.org/10.3350/cmh.2013.19.4.370CrossRefPubMedPubMedCentral

202.

Schwabl P, Bota S, Salzl P, Mandorfer M, Payer BA, Ferlitsch A, Stift J, Wrba F, Trauner M, Peck‐Radosavljevic M, Reiberger T (2015) New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertension. Liver International 35 (2):381-390. https://doi.org/10.1111/liv.12623CrossRefPubMed

203.

Kitson MT, Roberts SK, Colman JC, Paul E, Button P, Kemp W (2015) Liver stiffness and the prediction of clinically significant portal hypertension and portal hypertensive complications. Scand J Gastroenterol 50 (4):462-469. https://doi.org/10.3109/00365521.2014.964758CrossRefPubMed

204.

Cho EJ, Kim MY, Lee J-H, Lee IY, Lim YL, Choi DH, Kim YJ, Yoon J-H, Baik SK (2015) Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis. PLOS ONE 10 (7):e0133935. https://doi.org/10.1371/journal.pone.0133935CrossRefPubMedPubMedCentral

205.

Zykus R, Jonaitis L, Petrenkienė V, Pranculis A, Kupčinskas L (2015) Liver and spleen transient elastography predicts portal hypertension in patients with chronic liver disease: a prospective cohort study. BMC Gastroenterol 15 (1):183. https://doi.org/10.1186/s12876-015-0414-zCrossRefPubMedPubMedCentral

206.

Kumar A, Nm K, Sa A, P S, N B, V S, A A (2017) Correlation of transient elastography with hepatic venous pressure gradient in patients with cirrhotic portal hypertension: A study of 326 patients from India. World Journal of Gastroenterology 23 (4):687-696. https://doi.org/10.3748/wjg.v23.i4.687CrossRefPubMedPubMedCentral

207.

Salzl P, Reiberger T, Ferlitsch M, Payer BA, Schwengerer B, Trauner M, Peck-Radosavljevic M, Ferlitsch A (2014) Evaluation of portal hypertension and varices by acoustic radiation force impulse imaging of the liver compared to transient elastography and AST to platelet ratio index. Ultraschall Med 35 (6):528-533. https://doi.org/10.1055/s-0034-1366506CrossRefPubMed

208.

Procopet B, Berzigotti A, Abraldes JG, Turon F, Hernandez-Gea V, García-Pagán JC, Bosch J (2015) Real-time shear-wave elastography: Applicability, reliability and accuracy for clinically significant portal hypertension. Journal of Hepatology 62 (5):1068-1075. https://doi.org/10.1016/j.jhep.2014.12.007CrossRefPubMed

209.

Kim TY, Jeong WK, Sohn JH, Kim J, Kim MY, Kim Y (2015) Evaluation of portal hypertension by real-time shear wave elastography in cirrhotic patients. Liver International 35 (11):2416-2424. https://doi.org/10.1111/liv.12846CrossRefPubMed

210.

Lee CM, Jeong WK, Lim S, Kim Y, Kim J, Kim TY, Sohn JH (2016) Diagnosis of Clinically Significant Portal Hypertension in Patients with Cirrhosis: Splenic Arterial Resistive Index versus Liver Stiffness Measurement. Ultrasound Med Biol 42 (6):1312-1320. https://doi.org/10.1016/j.ultrasmedbio.2016.01.026CrossRefPubMed

211.

Jansen C, Bogs C, Verlinden W, Thiele M, Möller P, Görtzen J, Lehmann J, Vanwolleghem T, Vonghia L, Praktiknjo M, Chang J, Krag A, Strassburg CP, Francque S, Trebicka J (2017) Shear-wave elastography of the liver and spleen identifies clinically significant portal hypertension: A prospective multicentre study. Liver International 37 (3):396-405. https://doi.org/10.1111/liv.13243CrossRefPubMed

212.

Zhu Y-l, Ding H, Fu T-t, Peng S-y, Chen S-y, Luo J-j, Wang W-p (2019) Portal hypertension in hepatitis B-related cirrhosis: Diagnostic accuracy of liver and spleen stiffness by 2-D shear-wave elastography. Hepatology Research 49 (5):540-549. https://doi.org/10.1111/hepr.13306CrossRefPubMed

213.

Elkrief L, Ronot M, Andrade F, Dioguardi Burgio M, Issoufaly T, Zappa M, Roux O, Bissonnette J, Payance A, Lebrec D, Francoz C, Soubrane O, Valla D, Durand F, Vilgrain V, Castera L, Rautou PE (2018) Non-invasive evaluation of portal hypertension using shear-wave elastography: analysis of two algorithms combining liver and spleen stiffness in 191 patients with cirrhosis. Aliment Pharmacol Ther 47 (5):621-630. https://doi.org/10.1111/apt.14488CrossRefPubMed

214.

Attia D, Schoenemeier B, Rodt T, Negm AA, Lenzen H, Lankisch TO, Manns M, Gebel M, Potthoff A (2015) Evaluation of Liver and Spleen Stiffness with Acoustic Radiation Force Impulse Quantification Elastography for Diagnosing Clinically Significant Portal Hypertension. Ultraschall in Med 36 (06):603-610. https://doi.org/10.1055/s-0041-107971CrossRef

Title: Noninvasive imaging assessment of portal hypertension
Authors: Paul Kennedy
Octavia Bane
Stefanie J. Hectors
Aaron Fischman
Thomas Schiano
Sara Lewis
Bachir Taouli
Publication date: 01-11-2020
Publisher: Springer US
Keywords: Magnetic Resonance Imaging
Magnetic Resonance Imaging
Hypertension
Portal Hypertension
Portal Hypertension
Published in: Abdominal Radiology / Issue 11/2020
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-020-02729-7

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 11/2020

Multiparametric MR mapping in clinical decision-making for diffuse liver disease

Impact of PTFE-covered stent position and extension on TIPS patency

Magnetic resonance imaging of the prostate after focal therapy with high-intensity focused ultrasound

The tobacco flecks

Liver regeneration in recipients after living-donor liver transplantation in using preoperative CT texture analysis and clinical features; methodological issues on prediction

Diffusion-weighted imaging and texture analysis: current role for diffuse liver disease

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage